Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes

Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes

US Patent 9133478 · Granted Sep 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Virus-based expression vectors and uses thereof2021
Virus-based expression vectors and uses thereof2021
Intergenic sites between conserved genes in the genome of modified vaccinia anka2019
Intergenic sites between conserved genes in the genome of modified vaccinia anka2019
Intergenic sites between conserved genes in the genome of modified vaccinia anka2019
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Monoclonal antibodies against orthopoxviruses2017
Monoclonal antibodies against orthopoxviruses2017
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV 2016
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV 2016